Evaluation Of POLARIS AD-Aligned Enrollment Criteria And Longitudinal Outcomes In A Phase 2 AR1001 Study

mirodenafil (AR1001) - ariBio, Samjin Pharma

Hee Soo Choung1; Tianyang Xi, MD, PhD, MBA2; Fred Kim2; James Rock2; SangYun Kim, M.D.,Ph.D.3; Jai Jun Choung1.

Jun 30, 2026